Novo Nordisk A/S ADR (NVO)
70.01 x 5 70.08 x 3
Pre-market by (Cboe BZX)
71.73 -1.87 (-2.54%) 03/26/25 [NYSE]
70.01 x 5 70.08 x 3
Pre-market 70.03 -1.70 (-2.37%) 08:57 ET
for Thu, Mar 27th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,643,260 | 10,724,530 | 6,559,445 | 3,699,259 | 12,150,770 |
| Depreciation Amortization | 2,770,515 | 2,050,187 | 1,696,824 | 424,278 | 1,366,768 |
| Accounts receivable | -1,040,955 | N/A | N/A | N/A | -2,063,292 |
| Accounts payable and accrued liabilities | 469,800 | N/A | N/A | N/A | 1,454,759 |
| Other Working Capital | 1,492,340 | -1,623,464 | 35,931 | -1,288,851 | 2,903,710 |
| Other Operating Activity | -794,600 | 4,866,267 | 1,060,893 | -750,568 | 725 |
| Operating Cash Flow | $17,540,360 | $16,017,520 | $9,353,093 | $2,084,118 | $15,813,440 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 777,635 | -269,447 | 890,620 | 1,889,888 | -690,862 |
| PPE Investments | -6,838,780 | -4,578,539 | -2,733,619 | -1,233,814 | -3,747,031 |
| Net Acquisitions | -11,913,630 | -98,463 | -96,392 | N/A | N/A |
| Purchase Of Investment | -113,970 | -63,824 | -4,618 | -2,184 | -39,349 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 4,792 |
| Purchase Sale Intangibles | -601,025 | -543,611 | -476,623 | -77,896 | -1,900,668 |
| Other Investing Activity | -601,035 | -543,611 | -476,624 | -77,896 | -1,900,668 |
| Investing Cash Flow | $-18,689,780 | $-5,553,885 | $-2,420,633 | $575,994 | $-6,373,118 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 5,087,216 | 4,980,226 | N/A | N/A |
| Debt Issued | 11,511,700 | 17,541 | N/A | N/A | N/A |
| Debt Repayment | -918,575 | -869,955 | -774,891 | -46,155 | -213,008 |
| Common Stock Repurchased | -2,926,245 | -1,870,506 | -1,484,125 | -412,922 | -4,344,965 |
| Dividend Paid | -6,400,300 | -6,506,236 | -4,120,775 | -4,157,899 | -4,612,568 |
| Other Financing Activity | -5 | 0 | -1 | 775,757 | -1 |
| Financing Cash Flow | $1,266,575 | $-4,141,940 | $-1,399,566 | $-3,841,219 | $-9,170,542 |
| Exchange Rate Effect | 65,975 | -38,619 | 12,410 | 6,406 | -17,279 |
| Beginning Cash Position | 2,086,840 | 2,121,381 | 2,076,766 | 2,095,475 | 1,837,216 |
| End Cash Position | 2,269,975 | 8,404,453 | 7,622,070 | 920,774 | 2,089,719 |
| Net Cash Flow | $183,135 | $6,283,072 | $5,545,305 | $-1,174,701 | $252,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,540,360 | 16,017,520 | 9,353,093 | 2,084,118 | 15,813,440 |
| Capital Expenditure | -6,838,780 | -4,578,686 | -2,733,619 | -1,233,814 | -3,747,031 |
| Free Cash Flow | 10,701,580 | 11,438,834 | 6,619,474 | 850,304 | 12,066,409 |